Northeast Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-4,010
| Closed | -$215K | – | 159 |
|
|
2016
Q1 | $215K | Buy |
4,010
+163
| +4% | +$8.74K | 0.02% | 149 |
|
|
2015
Q4 | $253K | Hold |
3,847
| – | – | 0.03% | 133 |
|
|
2015
Q3 | $217K | Buy |
3,847
+185
| +5% | +$10.4K | 0.02% | 150 |
|
|
2015
Q2 | $216K | Sell |
3,662
-75
| -2% | -$4.42K | 0.02% | 150 |
|
|
2015
Q1 | $233K | Hold |
3,737
| – | – | 0.02% | 152 |
|
|
2014
Q4 | $215K | Sell |
3,737
-38
| -1% | -$2.19K | 0.02% | 163 |
|
|
2014
Q3 | $203K | Buy |
+3,775
| New | +$203K | 0.02% | 174 |
|
|
2014
Q2 | – | Sell |
-3,820
| Closed | -$202K | – | 180 |
|
|
2014
Q1 | $202K | Buy |
+3,820
| New | +$202K | 0.02% | 166 |
|
|
2013
Q4 | – | Sell |
-5,867
| Closed | -$222K | – | 171 |
|
|
2013
Q3 | $222K | Sell |
5,867
-76
| -1% | -$2.88K | 0.03% | 150 |
|
|
2013
Q2 | $233K | Buy |
+5,943
| New | +$233K | 0.03% | 140 |
|